Showing results (181-190 of 269) with videos related to

Sort By:
Pageof 27
American Journal of Hematology|December 17, 2017
Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adultsAlexandra Serris, Zahir Amoura, Florence Canouï-Poitrine, et al.
American Journal of Hematology|October 4, 2016
A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)Marc Michel, Louis Terriou, Francoise Roudot-Thoraval, et al.
Autoimmunity Reviews|December 29, 2015
Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysisGuillaume Moulis, Alexandra Audemard-Verger, Laurent Arnaud, et al.
British Journal of Haematology|March 19, 2016
Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patientsLouise Nielsen, Florence Canouï-Poitrine, Jean-Philippe Jais, et al.
Blood|September 14, 2017
Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell diseaseSanne M Meinderts, Joep W R Sins, Karin Fijnvandraat, et al.
Retina (Philadelphia, Pa.)|April 12, 2021
CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME AND POSTERIOR OCULAR INVOLVEMENT: Case Series of 11 Patients and Literature ReviewNathalie Morel, Clémence Bonnet, Hanane Mehawej, et al.
European Journal of Haematology|September 1, 2022
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphomaAdrien Daniel, David Ghez, Camille Ravaiau, et al.
British Journal of Haematology|July 27, 2019
Survival and specific outcome of sickle cell disease patients after renal transplantationChristel Gérardin, Anissa Moktefi, Cécile Couchoud, et al.
Pageof 27